Autres langues Eaton Vance Ohio Municipal Income Trust

Actions

EVO

US27826G1094

Temps Différé Nyse Autres places de cotation 21:48:08 18/01/2019			Varia. 5j.	Varia. 1 janv.
12,62 ^USD	+0,08 %		-0,24 %	+3,95 %

07/02	Mise à jour sectorielle : Les actions du secteur de la santé progressent dans l'après-midi	MT
07/02	Une unité d'Evotec et Advanced BioScience élargissent leur accord de développement d'anticorps contre le VIH	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Evotec, Variant Bio Launch Partnership to Develop Treatments for Fibrosis	18/04
Evotec Grants Claris Ventures Portfolio Biotech Firms Access to Testing Platform	06/03
Sector Update: Health Care Stocks Advance in Afternoon Trading	07/02
Evotec Unit, Advanced BioScience Expand Agreement to Develop Antibodies Against HIV	07/02
Evotec Says Former CEO Failed to Disclose Stock Trades Over 3 Years	22/01
Evotec Collaborates With Crohn's & Colitis Foundation on Inflammatory Bowel Disease Therapies	10/01
Evotec Gets $25 Million Payment Under Neuroscience Partnership With Bristol Myers Squibb	08/01
Sector Update: Health Care Stocks Advance Pre-Bell Thursday	04/01
US Equity Futures Narrowly Mixed Pre-Bell as Traders Refrain From Making Big Bets Ahead of Friday's Jobs Report	04/01
Sector Update: Health Care	04/01
Top Premarket Decliners	04/01
Evotec CEO Werner Lanthaler Steps Down; Former COO Mario Polywka Named Interim CEO; Shares Fall Pre-Bell	04/01
Evotec Partners With Owkin to Accelerate Therapeutics Pipeline Using Artificial Intelligence	04/01
Evotec Obtains $2.5 Million Grant From Bill & Melinda Gates Foundation for Teratogenicity Platform	19/12
Sector Update: Health Care Stocks Rise Pre-Bell Thursday	14/12
Federal Reserve Outlook Pushes Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday	14/12
Evotec Teams Up With Charite Universitatsmedizin Berlin to Generate Molecular Patient Database	14/12
Evotec Says Partner Obtained Regulatory Approval in China for Insomnia Drug	06/12
Evotec Q3 Net Loss Narrows as Revenue Rises; Reaffirms 2023 Revenue Outlook	08/11
Evotec Unveils Collaboration With Dewpoint Therapeutics to Advance Oncology Programs	07/11

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Eaton Vance Ohio Municipal Income Trust

Actions

EVO

US27826G1094

Autres langues

Filtres